Combined use of oral chelators and desferrioxamine in thalassemia.
Piga
A
A
Thalassemia Center, Department of Pediatric Hematology-Oncology, University of Torino, Italy. antonio.piga@unito.it
Roggero
S
S
Marletto
F
F
Sacchetti
L
L
Longo
F
F
D002614:Chelating Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D003676:Deferoxamine / Q000008:administration & dosage / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D013789:Thalassemia / Q000188:drug therapy*; D016896:Treatment Outcome
D002614:Chelating Agents; D003676:Deferoxamine